22 | Proteins (Proteins, Gene)FDA Link
03/2021
-
02/2003 |
19 | Pharmaceutical PreparationsIBA
01/2020
-
04/2002 |
14 | OligonucleotidesIBA
06/2007
-
01/2002 |
13 | Biological ProductsIBA
09/2018
-
06/2008 |
11 | Antisense OligonucleotidesIBA
09/2006
-
04/2002 |
10 | GemcitabineFDA Link
10/2018
-
03/2004 |
9 | GinsenosidesIBA
01/2018
-
03/2007 |
8 | Oncogene Proteins (Oncogene Protein)IBA
10/2019
-
02/2005 |
7 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2016
-
12/2011 |
7 | Antineoplastic Agents (Antineoplastics)IBA
07/2015
-
04/2002 |
6 | Messenger RNA (mRNA)IBA
03/2021
-
09/2005 |
6 | Therapeutic UsesIBA
10/2014
-
04/2002 |
5 | Transcription Factors (Transcription Factor)IBA
05/2016
-
01/2005 |
5 | Carboplatin (JM8)FDA LinkGeneric
07/2009
-
03/2004 |
5 | Irinotecan (Camptosar)FDA LinkGeneric
11/2007
-
01/2002 |
4 | DNA (Deoxyribonucleic Acid)IBA
01/2022
-
05/2002 |
4 | UbiquitinIBA
05/2018
-
03/2007 |
4 | Proto-Oncogene Proteins c-mdm2IBA
01/2018
-
09/2005 |
4 | 7- (benzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA
01/2017
-
07/2010 |
4 | Biomarkers (Surrogate Marker)IBA
12/2015
-
04/2007 |
4 | iminoquinoneIBA
07/2015
-
07/2010 |
4 | 7- (4- fluorobenzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA
05/2012
-
05/2009 |
4 | Dexamethasone (Maxidex)FDA LinkGeneric
03/2009
-
03/2004 |
4 | Docetaxel (Taxotere)FDA Link
06/2008
-
08/2005 |
3 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2020
-
03/2007 |
3 | 6- methoxy- 1- (naphthalen- 1- yl)- 9H- pyrido(3,4- b)indoleIBA
01/2020
-
10/2014 |
3 | indoleIBA
12/2018
-
10/2014 |
3 | artemisinin (artemisinine)IBA
01/2017
-
09/2008 |
3 | 25-methoxylprotopanaxadiolIBA
08/2015
-
06/2009 |
3 | Cisplatin (Platino)FDA LinkGeneric
03/2015
-
08/2002 |
3 | Hormones (Hormone)IBA
01/2015
-
02/2005 |
3 | N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA
05/2014
-
05/2013 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012
-
04/2007 |
3 | Death Domain ReceptorsIBA
01/2012
-
07/2009 |
3 | CaspasesIBA
01/2012
-
05/2009 |
3 | 25-hydroxyprotopanaxadiolIBA
01/2011
-
06/2008 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
12/2003
-
01/2002 |
2 | EnzymesIBA
01/2021
-
10/2015 |
2 | Peptides (Polypeptides)IBA
01/2020
-
01/2005 |
2 | Protein Isoforms (Isoforms)IBA
01/2020
-
12/2014 |
2 | MA242IBA
10/2019
-
10/2018 |
2 | Proteasome Endopeptidase Complex (Proteasome)IBA
05/2018
-
03/2014 |
2 | Disulfiram (Antabuse)FDA Link
01/2018
-
03/2014 |
2 | AndrogensIBA
01/2017
-
09/2008 |
2 | artenimol (dihydroartemisinin)IBA
01/2017
-
07/2009 |
2 | Monoclonal AntibodiesIBA
04/2016
-
01/2015 |
2 | AntibodiesIBA
01/2015
-
01/2005 |
2 | Tyrosine Kinase InhibitorsIBA
05/2014
-
05/2013 |
2 | A-Form DNA (A-DNA)IBA
05/2014
-
03/2014 |
2 | (5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
05/2014
-
01/2014 |
2 | Aurora Kinase BIBA
01/2014
-
05/2013 |
2 | LigandsIBA
07/2013
-
09/2006 |
2 | Small Interfering RNA (siRNA)IBA
05/2013
-
11/2005 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012
-
01/2005 |
2 | AlkaloidsIBA
01/2011
-
05/2009 |
2 | Toll-Like Receptor 9IBA
06/2007
-
06/2006 |
2 | Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
04/2007
-
07/2002 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2007
-
09/2006 |
2 | Nucleic AcidsIBA
05/2006
-
01/2005 |
2 | E2F Transcription FactorsIBA
11/2005
-
09/2003 |
1 | ResveratrolIBA
10/2021 |
1 | Glucose (Dextrose)FDA LinkGeneric
10/2021 |
1 | Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2021 |
1 | Urea (Carbamide)FDA LinkGeneric
01/2021 |
1 | CollagenIBA
01/2021 |